belodin 10 mg/1 tableta tableta
farmavita d.o.o. sarajevo - loratadine - tableta - 10 mg/1 tableta - 1 tableta sadrži: 10 mg loratadina
loramin 10 mg/1 tableta tableta
zada pharmaceuticals d.o.o. - loratadine - tableta - 10 mg/1 tableta - 1 tableta sadrži: 10 mg loratadina
aerogal 0,5 mg/1 ml sirup
galenika d.o.o. - desloratadin - sirup - 0,5 mg/1 ml - 1 ml sirupa sadrži 0,5 mg desloratadina
intelence
janssen-cilag international nv - Этравирин - hiv infekcije - non-nucleoside reverse transcriptase inhibitors, antivirals for systemic use - intelence, u kombinaciji s jačanju proteaze i druge antiretrovirusne lijekove, je indiciran za liječenje ljudskih-imunodeficijencije-virus-tip-1 (hiv-1) infekcije u odraslih bolesnika s antiretrovirusne liječeni i antiretrovirusne liječeni pedijatrijskih bolesnika od šest godina. ovaj prikaz se temelji na tjedan-48 analize dvije faze iii kliničkih ispitivanja vrhunski obučena pacijenata, gdje Интеленс proučavan je u kombinaciji s optimiziranim sheme (arr), koja je uključivala дарунавир/ritonavir. napomena u pedijatrijskoj oboljelih se temelji na 48-tjedan analiza jednom rukom, u drugoj fazi suđenja u arv-liječenje-iskusan pedijatrijska bolesnika.
lynparza
astrazeneca ab - olaparib - neoplazme jajnika - antineoplastična sredstva - jajnika cancerlynparza prikazan kao monoterapija za:podržava liječenje odraslih bolesnika s поздними (figo faze iii i iv) u genima brca1/2-mutirani (зародышевой linije i/ili somatskih) brzorezni epitela jajnika, masterbatch cijevi ili primarni перитонеальный rak, koji u odgovor (potpuno ili djelomično) nakon završetka prve linije na bazi platine kemoterapije. maintenance treatment of adult patients with platinum sensitive relapsed high grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy. lynparza in combination with bevacizumab is indicated for the:maintenance treatment of adult patients with advanced (figo stages iii and iv) high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy in combination with bevacizumab and whose cancer is associated with homologous recombination deficiency (hrd) positive status defined by either a brca1/2 mutation and/or genomic instability (see section 5. breast cancerlynparza is indicated as:monotherapy or in combination with endocrine therapy for the adjuvant treatment of adult patients with germline brca1/2-mutations who have her2-negative, high risk early breast cancer previously treated with neoadjuvant or adjuvant chemotherapy (see sections 4. 2 i 5. monotherapy for the treatment of adult patients with germline brca1/2-mutations, who have her2 negative locally advanced or metastatic breast cancer. pacijenti moraju prethodno bile tretirane s антрациклина i таксана u (neo)adjuvantne ili метастатический, ako pacijenti nisu prikladni za tih postupaka (vidi odjeljak 5. pacijenti s receptore hormona (h)-pozitivnog raka dojke treba također razvili ili nakon pre-hormonska terapija, ili se smatraju neprikladnim za endokrine terapije. adenocarcinoma of the pancreaslynparza is indicated as:monotherapy for the maintenance treatment of adult patients with germline brca1/2-mutations who have metastatic adenocarcinoma of the pancreas and have not progressed after a minimum of 16 weeks of platinum treatment within a first-line chemotherapy regimen. prostate cancerlynparza is indicated as:monotherapy for the treatment of adult patients with metastatic castration-resistant prostate cancer (mcrpc) and brca1/2-mutations (germline and/or somatic) who have progressed following prior therapy that included a new hormonal agent. in combination with abiraterone and prednisone or prednisolone for the treatment of adult patients with mcrpc in whom chemotherapy is not clinically indicated (see section 5.
lynparza 50mg kapsula, tvrda
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - olaparib - kapsula, tvrda - 50mg
lynparza 100mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - olaparib - film tableta - 100mg
lynparza 150mg film tableta
druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - olaparib - film tableta - 150mg
zepatier
merck sharp & dohme b.v. - danas tvrtka otvara, razvija, grazoprevir - hepatitis c, kronični - direct acting antivirals, antivirals for systemic use, antivirals for treatment of hcv infections - zepatier is indicated for the treatment of chronic hepatitis c (chc) in adult and paediatric patients 12 years of age and older who weigh at least 30 kg (see sections 4. 2, 4. 4 i 5. virus hepatitisa c (hcv) genotip-specifične aktivnosti vidi 4. 4 i 5.
polibevit 25 mg/1 tableta+ 5 mg/1 tableta+ 5 mg/1 tableta+ 4 mg/1 tableta+ 2 mg/1 tableta+ 0,002 mg/1 tableta film tableta
bosnalijek d.d. - cijanokobalamin, kalcijumpantotenat, nikotinamid, piridoksin, riboflavin, tiamin - film tableta - 25 mg/1 tableta+ 5 mg/1 tableta+ 5 mg/1 tableta+ 4 mg/1 tableta+ 2 mg/1 tableta+ 0,002 mg/1 tableta - 1 film tableta sadrži: 25,000 mg nikotinamid; 5,000 mg vitamin b2 (riboflavin); 5,000 mg kalcijumpantotenat; 4,000 mg vitamin b1 (tiaminnitrat); 2,000 mg vitamin b6 (piridoksinhidrohlorid); 0,002 mg cijanokobalamin (vitamin b12)